Tuesday, June 8
Bonus Session: A Primer on Regenerative Medicine Science and Recent Breakthroughs
Heather C. Hatcher, Regulatory Scientist, Womble Bond Dickinson (US) LLP
Collin Stabler, Senior Associate, Exponent, Inc.
Moderated by Barbara A. Binzak Blumenfeld, Shareholder, Buchanan Ingersoll & Rooney PC
FDLI Welcome and Introduction
Amy Comstock Rick, President & CEO, FDLI
Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA
Updates on FDA’s Comprehensive Regenerative Medicine Policy Framework
Wilson W. Bryan, Director, Office of Tissues and Advanced Therapies, CBER, FDA
Lauren A. Miller, Senior Counsel, AbbVie
Moderated by Joanne Hawana, Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.